Lung Cancer Radiation Therapy: Less is More

Image

Radiotherapy at a higher-than-standard dose is harmful to patients with locally advanced non-small cell lung cancer (NSCLC) who are also getting concurrent and consolidation chemotherapy, a study has found. Patients with stage III NSCLC who were given the standard 60 gray (Gy) dose of radiotherapy lived approximately nine months longer and experienced fewer treatment-related deaths than those treated with a high dose of 74 Gy. Those who received the high dose faced a 56% greater risk of death and a 37% greater risk of local progression of their disease compared with patients who received the standard dose, according to lead author Jeffrey D. Bradley, MD. This is a critical study in the field of radiation oncology,” said ASCO President Sandra M. Swain, MD. After a decade of research, we can finally close the chapter on the high-dose vs standard-dose therapy debate in lung cancer, You now have evidence that standard doses of radiation therapy for stage III non-small cell lung cancer are the gold standard for treatment. For more information on lung cancer, look for my new e-book for IPad (Understanding Lung Cancer in 60 Minutes) coming out this month. I’m Dr. Michael Hunter.

Published by

understandcancerin60minutes

Harvard AB Yale MD UPenn Radiation Oncology Radiation Oncologist, Seattle area

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s